Zy Therapeutics News
Advancing Our Science and Engaging Our Community
Stay informed about Zy Therapeutics’ latest progress, scientific presentations, publications, and community engagement efforts as we work to advance ZY-001 for rare CNS disorders.
Building Strategic Partnerships at AES 2025
As Zy Therapeutics prepares for the 2025 American Epilepsy Society (AES) Annual Meeting, the company is placing a strong emphasis…
Read More
Zy Therapeutics to Highlight Kamini’s Clinical and Regulatory Progress at AES 2025
Zy Therapeutics is gearing up for an important presence at the 2025 American Epilepsy Society (AES) Annual Meeting, where the…
Read More
Zy Therapeutics to Convene Scientific Advisory Board Meeting at AES 2025
Zy Therapeutics will convene its 2025 Scientific Advisory Board (SAB) meeting during the American Epilepsy Society (AES) Annual Meeting on…
Read More
ZY Therapeutics develops Kamini for brain calcification in rare CNS diseases
Brain calcification is more than a radiographic finding, it’s a devastating driver of seizures, migraines, and cognitive decline in rare…
Read More
Zy Therapeutics Shares New Data at ASENT 2024
Zy Therapeutics is presenting new research findings at the American Society for Experimental Neurotherapeutics (ASENT) annual meeting, taking place in…
Read More